Nucl Med Mol Imaging.  2009 Dec;43(6):509-512.

Clinical Application of (18)F-FDG PET in Multiple Myeloma

Affiliations
  • 1Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. jynm.choi@samsung.com

Abstract

This review focuses on the clinical use of (18)F-FDG PET to evaluate multiple myeloma. (18)F-FDG PET is useful for diagnosis, staging of multiple myeloma and differential diagnosis of myeloma related disease such as monoclonal gammopathy of undetermined significance or plasmacytoma. For therapy response, (18)F-FDG PET may be effective after chemotherapy for multiple myeloma and radiotherapy for plasmacytoma.

Keyword

Multiple myeloma; (18)F-FDG; PET; clinical application

MeSH Terms

Diagnosis, Differential
Monoclonal Gammopathy of Undetermined Significance
Multiple Myeloma
Plasmacytoma
Full Text Links
  • NMMI
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr